Skip to main content
Ilene Weitz, MD, Hematology, Los Angeles, CA

IleneWeitzMD

Hematology Los Angeles, CA

Professor of Clinical Medicine, USC School of Medicine

Dr. Weitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Weitz's full profile

Already have an account?

  • Office

    1441 Eastlake Ave
    Los Angeles, CA 90089
    Phone+1 323-865-3105
    Fax+1 213-861-5863

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1976 - 1979
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012

Publications & Presentations

PubMed

Lectures

  • Aware of the Rare: Diagnosing and Treating Immune-Mediated Hematologic Disorders 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel Method
    Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel MethodDecember 8th, 2020
  • Subcutaneous Formulations of Apellis’ Pegcetacoplan and Alexion’s Ultomiris in PNH Draw Doubt for Wide Utility
    Subcutaneous Formulations of Apellis’ Pegcetacoplan and Alexion’s Ultomiris in PNH Draw Doubt for Wide UtilitySeptember 16th, 2020
  • FDA Approves Ultomiris
    FDA Approves UltomirisDecember 21st, 2018